Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.

Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.

Item
http://www.wikidata.org/entity/Q33987492
Allosteric regulation of HIV-1 reverse transcriptase by ATP for nucleotide selection.Genomic mutation rates that neutralize adaptive evolution and natural selectionDaily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutralityNature, position, and frequency of mutations made in a single cycle of HIV-1 replication.Retroviral vectors for analysis of viral mutagenesis and recombination.5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytesPersistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP.Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector.Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.Interrelationship between HIV-1 fitness and mutation rate.Development of a liposomal nanodelivery system for nevirapineAntiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur
P2860

Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.

Item
http://www.wikidata.org/entity/Q33987492
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@ast
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@en
type
label
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@ast
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@en
prefLabel
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@ast
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Human immunodeficiency virus m ...... s type 1 mutation frequencies.
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.79.18.12045-12057.2005
P407
P433
P478
P577
P698
P932